CatalystPit

CLYMClimb Bio, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $11.47 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$658.79M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-30 · RA CAPITAL MANAGEMENT, L.P. (Director) · OTHER
  • 2026-09-17 · Thomas Stephen Basil (Director) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders117
Shares held61,267,286
Value$730.01M
Percent of shares outstanding106.67%
As of quarter end2026-06-30
RECENT NEWS
  • Climb Bio: Others Proved APRIL Works, So The Bet Is On The 12-Week Dosing Interval
  • Climb Bio to present Phase 2 data for budoprutug at ASN Kidney Week
  • Climb Bio presents two lead drugs with long runway at Morgan Stanley conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Climb Bio, Inc. (CLYM) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit